Bernard Levin

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi request reprint Implementation of colorectal cancer screening: the challenge
    Bernard Levin
    The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Curr Opin Gastroenterol 18:82-6. 2002
  2. ncbi request reprint Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable
    Bernard Levin
    Division of Cancer Prevention, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 95:1618-28. 2002
  3. ncbi request reprint Molecular screening testing for colorectal cancer
    Bernard Levin
    University of Texas M D Anderson Cancer Center, Houston, Texas 90033 0804, USA
    Clin Cancer Res 12:5014-7. 2006
  4. doi request reprint Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
    Bernard Levin
    The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Gastroenterology 134:1570-95. 2008
  5. pmc Global quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool
    Patrick M Lynch
    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Gastrointest Endosc 77:455-63. 2013
  6. doi request reprint Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
    Bernard Levin
    The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    CA Cancer J Clin 58:130-60. 2008
  7. ncbi request reprint Prevalence of colorectal cancer screening in a large medical organization
    Sarah T Hawley
    Baylor College of Medicine, Department of Family and Community Medicine, Houston, Texas 77098, USA
    Cancer Epidemiol Biomarkers Prev 13:314-9. 2004
  8. ncbi request reprint Unusually high rate of young-onset pancreatic cancer in the East Nile Delta region of Egypt
    Amr S Soliman
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center Houston, TX 77030, USA
    Int J Gastrointest Cancer 32:143-51. 2002
  9. ncbi request reprint Molecular stool sample assays for colorectal cancer screening
    Bernard Levin
    The University of Texas M D Anderson Cancer Center, USA
    Clin Adv Hematol Oncol 3:907-8. 2005
  10. ncbi request reprint Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers
    Bernard Levin
    The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    CA Cancer J Clin 53:44-55. 2003

Research Grants

Detail Information

Publications42

  1. ncbi request reprint Implementation of colorectal cancer screening: the challenge
    Bernard Levin
    The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Curr Opin Gastroenterol 18:82-6. 2002
    ..This article is a summary of recently published information on cost-effectiveness of colorectal screening, attempts to enhance acceptance and compliance by physicians and the public, and legislative efforts to ensure access to screening...
  2. ncbi request reprint Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable
    Bernard Levin
    Division of Cancer Prevention, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 95:1618-28. 2002
    ....
  3. ncbi request reprint Molecular screening testing for colorectal cancer
    Bernard Levin
    University of Texas M D Anderson Cancer Center, Houston, Texas 90033 0804, USA
    Clin Cancer Res 12:5014-7. 2006
  4. doi request reprint Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
    Bernard Levin
    The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Gastroenterology 134:1570-95. 2008
    ..It is the strong opinion of these 3 organizations that colon cancer prevention should be the primary goal of screening...
  5. pmc Global quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool
    Patrick M Lynch
    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Gastrointest Endosc 77:455-63. 2013
    ..Accurate measures of the total polyp burden in familial adenomatous polyposis (FAP) are lacking. Current assessment tools include polyp quantitation in limited-field photographs and qualitative total colorectal polyp burden by video...
  6. doi request reprint Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
    Bernard Levin
    The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    CA Cancer J Clin 58:130-60. 2008
    ..It is the strong opinion of these 3 organizations that colon cancer prevention should be the primary goal of screening...
  7. ncbi request reprint Prevalence of colorectal cancer screening in a large medical organization
    Sarah T Hawley
    Baylor College of Medicine, Department of Family and Community Medicine, Houston, Texas 77098, USA
    Cancer Epidemiol Biomarkers Prev 13:314-9. 2004
    ..2. Screening rates from medical record review were lower than those derived from physician self-report. Our findings underscore the need for interventions to improve CRC screening in primary care settings...
  8. ncbi request reprint Unusually high rate of young-onset pancreatic cancer in the East Nile Delta region of Egypt
    Amr S Soliman
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center Houston, TX 77030, USA
    Int J Gastrointest Cancer 32:143-51. 2002
    ..In Egypt, the disease has traditionally been considered rare, and there has not been a previous publication on its population-based incidence or age distribution...
  9. ncbi request reprint Molecular stool sample assays for colorectal cancer screening
    Bernard Levin
    The University of Texas M D Anderson Cancer Center, USA
    Clin Adv Hematol Oncol 3:907-8. 2005
  10. ncbi request reprint Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers
    Bernard Levin
    The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    CA Cancer J Clin 53:44-55. 2003
    ..Based on recommendations of the Advisory Group, only a minor modification has been made to the ACS's Recommendations for Screening and Surveillance of the Early Detection of Adenomatous Polyps and Colorectal Cancer...
  11. pmc The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis
    Imad Shureiqi
    Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
    Cancer Res 65:11486-92. 2005
    ..Therefore, 15-LOX-1 down-regulation rather than a shift in the balance of LOXs is likely the dominant alteration in LOX metabolism which contributes to colorectal tumorigenesis by repressing apoptosis...
  12. ncbi request reprint Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries
    Annie O Chan
    Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Clin Cancer Res 11:8281-7. 2005
    ..International differences in molecular pathology have not been studied extensively but have implications for the management of patients in different countries and of immigrant patients...
  13. ncbi request reprint Cancer prevention and the American Society of Clinical Oncology
    Scott M Lippman
    The University of Texas M D Anderson Cancer Center, Houston, USA
    J Clin Oncol 22:3848-51. 2004
  14. ncbi request reprint Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients
    Frank A Sinicrope
    Department of Gastrointestinal Medicine and Nutrition, University of Texas M D Anderson Cancer Center, Houston, USA
    Cancer Epidemiol Biomarkers Prev 13:920-7. 2004
    ....
  15. doi request reprint Disparities in colorectal screening between US-born and foreign-born populations: evidence from the 2000 National Health Interview Survey
    Ya Chen Tina Shih
    Section of Health Services Research, Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Cancer Educ 23:18-25. 2008
    ..This study examines the disparities in colorectal cancer (CRC) screening between US- and foreign-born groups and explores factors associated with such disparities...
  16. pmc Expert commentary--virtual colonoscopy: utility as a screening test for colorectal cancer?
    Michael L Kochman
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    MedGenMed 6:21. 2004
  17. ncbi request reprint Celecoxib for the prevention of colorectal adenomatous polyps
    Nadir Arber
    Integrated Cancer Prevention Center, Tel Aviv Sourasky Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    N Engl J Med 355:885-95. 2006
    ..Overexpression of cyclooxygenase 2 (COX-2) has been associated with colorectal adenomatous polyps and cancer, prompting researchers to propose its inhibition as a chemopreventive intervention...
  18. ncbi request reprint Detection of APC mutations in fecal DNA from patients with colorectal tumors
    Giovanni Traverso
    Graduate Program in Human Genetics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins School of Medicine, Baltimore, USA
    N Engl J Med 346:311-20. 2002
    ..The purpose of our study was to determine the feasibility of detecting APC mutations in fecal DNA with the use of newly developed methods...
  19. ncbi request reprint Colorectal Cancer Screening Clinical Practice Guidelines
    Bernard Levin
    J Natl Compr Canc Netw 4:384-420. 2006
  20. ncbi request reprint Recent developments in colorectal cancer screening and prevention
    Michael Pignone
    Division of General Internal Medicine, University of North Carolina at Chapel Hill School of Medicine, 27599 7110, USA
    Am Fam Physician 66:297-302. 2002
    ..This new information provides further support for efforts to increase the use of colorectal cancer screening and prevention services in adults older than 50 years...
  21. doi request reprint Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology
    Elizabeth G McFarland
    Radiology 248:717-20. 2008
  22. ncbi request reprint Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward
    Gary J Kelloff
    National Cancer Institute, Bethesda, Maryland 20852, USA
    Clin Cancer Res 12:3661-97. 2006
    ....
  23. ncbi request reprint Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees
    Amy S Oxentenko
    Mayo Clinic College of Medicine, Rochester, MN, USA
    J Cancer Educ 22:219-26. 2007
    ....
  24. doi request reprint Screening for nonpolypoid colorectal neoplasms
    Perry J Pickhardt
    JAMA 299:2743; author reply 2743-4. 2008
  25. ncbi request reprint Colorectal cancer screening education, prioritization, and self-perceived preparedness among primary care residents: data from a national survey
    Amy S Oxentenko
    Mayo Clinic College of Medicine, Rochester, MN, USA
    J Cancer Educ 22:208-18. 2007
    ....
  26. doi request reprint Chemoprevention of colorectal neoplasia: the potential for personalized medicine
    Nadir Arber
    Integrated Cancer Prevention Center, Tel Aviv Sourasky Medical Center and Tel Aviv University, Tel Aviv, Israel
    Gastroenterology 134:1224-37. 2008
    ..Possibly, combinations of agents will maximize effectiveness while limiting drug toxicity. Finally, personalized approaches will include the ability to predict risk and toxicity...
  27. ncbi request reprint Colonoscopy surveillance after polypectomy and colorectal cancer resection
    Durado D Brooks
    American Cancer Society, Atlanta, Georgia, USA
    Am Fam Physician 77:995-1002. 2008
    ....
  28. ncbi request reprint American Cancer Society guidelines for the early detection of cancer
    Robert A Smith
    Cancer Control Department, American Cancer Society, Atlanta, GA, USA
    CA Cancer J Clin 52:8-22. 2002
    ....
  29. ncbi request reprint Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas
    Scott D Solomon
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass 02115, USA
    Circulation 114:1028-35. 2006
    ..Cyclooxygenase-2 (COX-2) inhibitors have been shown to reduce colorectal adenomas but have been associated with increased cardiovascular risk...
  30. ncbi request reprint Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer
    Douglas K Rex
    Indiana University School of Medicine, Indianapolis, IN, USA
    CA Cancer J Clin 56:160-7; quiz 185-6. 2006
    ....
  31. ncbi request reprint Colorectal cancer screening for persons at average risk
    William F Anderson
    Division of Cancer Prevention Gastrointestinal and Other Cancer Research Group, National Cancer Institute, Bethesda, MD 20892 7117, USA
    J Natl Cancer Inst 94:1126-33. 2002
  32. ncbi request reprint Uptake of flexible sigmoidoscopy screening
    Bernard Levin
    Lancet 360:1172; author reply 1172-3. 2002
  33. ncbi request reprint Potential pitfalls in the use of surrogate endpoints in colorectal adenoma chemoprevention
    Bernard Levin
    J Natl Cancer Inst 95:697-9. 2003
  34. ncbi request reprint Multicolor in vitro translation
    Giovanni Traverso
    Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center, and Graduate Program in Human Genetics, Johns Hopkins School of Medicine, 1650 Orleans Street, Baltimore, Maryland 21231, USA
    Nat Biotechnol 21:1093-7. 2003
    ..This technology can be applied in various situations, including the simplified detection of rare truncating mutations in clinical samples from cancer patients...
  35. ncbi request reprint Colorectal cancer prevention
    Ernest T Hawk
    GI and Other Cancers Research Group, National Cancer Institute, 6130 Executive Boulevard, Suite 2141, Bethesda, MD 20892 7322, USA
    J Clin Oncol 23:378-91. 2005
    ..The threshold for tolerating toxicities is very low in asymptomatic individuals at minimally increased risk for colorectal neoplasia...
  36. ncbi request reprint Chemoprevention of colorectal cancer: ready for routine use?
    Nadir Arber
    Department of Cancer Prevention, Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, 6 Weizmann St, Tel Aviv 64239, Israel
    Curr Top Med Chem 5:517-25. 2005
    ..Pharmacology and genetics are collaborating to develop new chemoprevention agents designed to affect molecular targets linked to specific pre-malignant or predisposing conditions...
  37. ncbi request reprint Calcium plus vitamin D3 supplementation and colorectal cancer in women
    Michele R Forman
    N Engl J Med 354:752-4. 2006
  38. ncbi request reprint Chemoprevention of colorectal cancer: ready for routine use?
    Nadir Arber
    Department of Cancer Prevention, Tel Aviv Medical Center, 6 Weizmann St, 64239 Tel Aviv, Israel
    Recent Results Cancer Res 166:213-30. 2005
    ..Pharmacology and genetics are collaborating to develop new chemoprevention agents designed to affect molecular targets linked to specific premalignant or predisposing conditions...
  39. ncbi request reprint Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer
    Douglas K Rex
    Indiana University School of Medicine, Indianapolis, Indiana, USA
    Gastroenterology 130:1865-71. 2006
    ....
  40. ncbi request reprint Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
    Sidney J Winawer
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Gastroenterology 130:1872-85. 2006
    ..It has been shown that the first screening colonoscopy and polypectomy produces the greatest effects on reducing the incidence of colorectal cancer in patients with adenomatous polyps...
  41. ncbi request reprint Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
    Sidney J Winawer
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    CA Cancer J Clin 56:143-59; quiz 184-5. 2006
    ..It has been shown that the first screening colonoscopy and polypectomy produces the greatest effects on reducing the incidence of colorectal cancer in patients with adenomatous polyps...
  42. ncbi request reprint Detection of proximal colorectal cancers through analysis of faecal DNA
    Giovanni Traverso
    Lancet 359:403-4. 2002
    ..Using a sensitive method for microsatellite mutation detection, we found that 18 of 46 cancers had microsatellite alterations and that identical mutations could be identified in the faecal DNA of 17 of these 18 cases...

Research Grants1

  1. New Frontiers in Cancer 2003 Detection and Diagnosis
    Bernard Levin; Fiscal Year: 2003
    ..In an atmosphere focused on uniting biology, oncology and technology, physicians and scientists will have an opportunity to collaboratively develop clinical applications to improvement of patient care. ..